SCHEMBL26039652

SCHEMBL26039652

C=C(C)C(=O)OC(C)Cn1cc(-c2ccc(OC)cc2)c(=O)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.39
TYMP P19971 2/20 0.38
ERCC5 P28715 1/20 0.36
FEN1 P39748 1/20 0.36
GFER P55789 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ATM Q13315 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MAPT P10636 1/20 0.34
BACE1 P56817 1/20 0.34
GAA P10253 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26039859 0.91 ALDH1A1 (0.36) TYMSERCC5FEN1GFERL3MBTL1
SCHEMBL26034691 0.83 TYMS (0.42) TYMSTYMPERCC5FEN1GFER
SCHEMBL26039881 0.79 MET (0.38) TYMPGFERKDM4EALDH1A1LMNA
SCHEMBL26035400 0.77 CYP2C9 (0.44) TYMSGFERL3MBTL1ATMHDAC1
SCHEMBL26039659 0.77 GRIA1 (0.53) TYMPKDM4ELMNASMN1; SMN2MAPT
SCHEMBL26034726 0.76 ALDH1A1 (0.39) TYMSTYMPGFERL3MBTL1ATM
SCHEMBL26064061 0.72 GFER (0.35) TYMSTYMPGFERATMKDM4E
SCHEMBL26039535 0.72 PKM (0.52) ALDH1A1LMNA
SCHEMBL26034685 0.70 ASAH1 (0.45) TYMSKDM4EALDH1A1HPGD
SCHEMBL26039626 0.68 ASAH1 (0.42) HPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230273455-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273455-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6A, PDE6D TYMS 2848/4885TYMP 2921/4885ERCC5 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.